🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Cliff Asness’s BLFS Holdings & Trades

First Buy
Q2 2026
Duration Held
1 Quarters
Largest Add
Q2 2026
+15,739 Shares
Current Position
15,739 Shares
$444,469 Value

Cliff Asness's BLFS Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 15,739 shares of BioLife Solutions, Inc. (BLFS) worth $444,469, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.

Based on recent 13F filings, Cliff Asness has initiated a new position in BLFS, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's BioLife Solutions (BLFS) Holding Value Over Time

Track share changes against reported price movement

Quarterly BioLife Solutions (BLFS) Trades by Cliff Asness

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2026 +15,739 New Buy 15,739 $28.24

Cliff Asness's BioLife Solutions Investment FAQs

Cliff Asness first purchased BioLife Solutions, Inc. (BLFS) in Q2 2026, acquiring 15,739 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held BioLife Solutions, Inc. (BLFS) for 1 quarters since Q2 2026.

Cliff Asness's largest addition to BioLife Solutions, Inc. (BLFS) was in Q2 2026, adding 15,739 shares worth $444,469.

According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 15,739 shares of BioLife Solutions, Inc. (BLFS), valued at approximately $444,469.

As of the Q2 2026 filing, BioLife Solutions, Inc. (BLFS) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.

Cliff Asness's peak holding in BioLife Solutions, Inc. (BLFS) was 15,739 shares, as reported at the end of Q2 2026.